Home ENGLISH

ENGLISH

Latest

HiFiBiO buys up H-Immune, joining forces to ‘combat cancer’

admin -
0

Alnylam drops early filing plan for porphyria drug givosiran

admin -
0

New York biotech snaps up Eli Lilly neuro veteran as CSO

admin -
0

Roche puts up $125M to expand SQZ cell therapy pact

admin -
0

1 year after FDA snub, advisory committee recommends AcelRx’s Dsuvia for approval 10-3

admin -
0

‘Retina in a dish’ provides new insight into inherited blindness

admin -
0

Hoth Therapeutics seeks IPO cash to battle eczema

admin -
0

Adynxx merges with Alliqua, snagging Nasdaq listing ahead of pain trials

admin -
0

Chutes & Ladders—DFCI’s Nick Haining to become VP of oncology at Merck

admin -
0

Otsuka and Proteus sign 5-year, $88M digital pill partnership

admin -
0

Bristol-Myers, Compugen ally to test checkpoint combinations

admin -
0

Transforming mature neurons into dopamine factories could help fight brain diseases

admin -
0

Carrick bags ex-Onyx cancer drug, plans pivotal trials

admin -
0

CRISPR ‘tweezers’ relocate genes to change their function

admin -
0

Ionis may have found a home for dry AMD drug with Roche in $760M...

admin -
0

Ziopharm cuts Precigen ties, narrowing its R&D focus

admin -
0

Neurocrine, Jnana team up to discover CNS drugs

admin -
0

Lee Babiss’ Gotham raises $54M to drug mRNA-modifying proteins

admin -
0
123...1,458Page 1 of 1,458
©